Table 1.
Clinical characteristics (including medication usage) for individual migraine subjects.
| Subject ID | Age | Gender | Disease duration years |
Avg. migraine days/month | Visual aura | Medications for migraine |
|---|---|---|---|---|---|---|
| M01 | 34 | M | 20 | 12 | No | Excedrin migraine |
| M02 | 32 | M | 15 | 2 | No | Tylenol, ibuprofen |
| M03 | 49 | F | 39 | 13 | Yes | Imitrex |
| M04 | 36 | F | 20 | 12 | No | Aspirin, tylenol, ibuprofen |
| M05 | 34 | F | 14 | 14 | Yes | Excedrin |
| M06 | 24 | F | 8 | 6 | Yes | Tylenol, aleve, rizatriptan |
| M07 | 22 | F | 7 | 10 | No | Tylenol, ibuprofen |
| M08 | 25 | F | 7 | 10 | Yes | Ibuprofen |
| M09 | 22 | F | 3 | 2 | Yes | + Acetaminophen |
| M10 | 32 | F | 21 | 2 | Yes | Ibuprofen |
| M11 | 48 | F | 23 | 2 | No | None |
| M12 | 31 | F | 3 | 13 | No | Aspirin, ibuprofen |
| M13 | 37 | M | 33 | 2 | No | None |
| M14 | 24 | F | 4 | 1 | No | Tylenol |
| M15 | 26 | M | 3 | 10 | No | None |
| M16 | 30 | F | 9 | 4 | No | Naratriptan |
| M17 | 50 | F | 30 | 3 | Yes | Sumatriptan, ibuprofen |
| M18 | 50 | F | 15 | 4 | Yes | Imitrex, ibuprofen |
| M19 | 38 | F | 27 | 12 | Yes | Sumatriptan, ibuprofen, aspirin |
| M20 | 38 | F | 12 | 2 | No | Imitrex, naproxen |
| M21 | 32 | M | 26 | 7 | Yes | Tylenol |
| M22 | 32 | F | 14 | 6 | No | None |
| M23 | 41 | F | 23 | 3 | No | Ibuprofen |
| M24 | 46 | M | 6 | 6 | Yes | Ibuprofen, tylenol |
| M25 | 19 | F | 5 | 1 | Yes | None |
| M26 | 18 | M | 10 | 6 | No | None |
| M27 | 21 | M | 15 | 3 | No | Ibuprofen |
| M28 | 45 | F | 30 | 4 | Yes | Ibuprofen, excedrin |
| M29 | 29 | M | 12 | 3 | No | None |
| M30 | 23 | F | 10 | 5 | No | Acetaminophen |
| M31 | 22 | F | 3 | 14 | Yes | None |
| M32 | 39 | F | 6 | 6 | Yes | Excedrin |